Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/bjh.20022 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comprehensive clinico-genetic analysis reveals prognostic factors of blastic plasmacytoid dendritic cell neoplasm.
Br J Haematol
April 2025
Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea.
Primary Microgliopathy Presenting as Degenerative Dementias: A Case Series of Novel Gene Mutations from India.
Dement Geriatr Cogn Dis Extra
March 2024
Department of Neurology, National Institute of Mental Health, and Neurosciences (NIMHANS), Bengaluru, India.
Introduction: Microglia exert a crucial role in homeostasis of white matter integrity, and several studies highlight the role of microglial dysfunctions in neurodegeneration. Primary microgliopathy is a disorder where the pathogenic abnormality of the microglia causes white matter disorder and leads to a neuropsychiatric disease. Triggering receptor expressed on myeloid cells (), TYRO protein tyrosine kinase binding protein () and colony-stimulating factor 1 receptor () are genes implicated in primary microgliopathy.
View Article and Find Full Text PDFGenetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM study.
Parkinsonism Relat Disord
October 2022
Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg; Transversal Translational Medicine, Luxembourg Institute of Health, Strassen, Luxembourg; Parkinson Research Clinic, Centre Hospitalier de Luxembourg, Luxembourg.
Article Synopsis
- The study explores whether genetic variables can predict outcomes of subthalamic deep brain stimulation (STN-DBS) in patients with Parkinson's disease (PD).
- Researchers aimed to replicate an earlier finding that a specific genetic variant (SNCA rs356220) was linked to better STN-DBS responses and looked at additional genetic factors from recent genome-wide association studies (GWAS).
- Although the SNCA rs356220 variant didn't predict motor outcomes, it was associated with improved quality of life; other genetic markers showed predictive value for DBS outcomes, but polygenic risk scores were not useful in this context.
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.
Genome Biol
June 2015
Department of Pediatric Oncology and Hematology, University Children's Hospital of Cologne, Kerpener Strasse 62, D-50924, Cologne, Germany.
Background: Gene expression profiling is being widely applied in cancer research to identify biomarkers for clinical endpoint prediction. Since RNA-seq provides a powerful tool for transcriptome-based applications beyond the limitations of microarrays, we sought to systematically evaluate the performance of RNA-seq-based and microarray-based classifiers in this MAQC-III/SEQC study for clinical endpoint prediction using neuroblastoma as a model.
Results: We generate gene expression profiles from 498 primary neuroblastomas using both RNA-seq and 44 k microarrays.